| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| PROVECTUS BIOPHARMACEUTICALS, INC. | COO, Director | Series D-1 Convertible Preferred Stock | 38,473 | 20 Jun 2021 | Direct | ||
| PROVECTUS BIOPHARMACEUTICALS, INC. | COO, Director | 8% Secured Convertible Promissory Notes due 2021 | 0 | 20 Jun 2021 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| PVCT | PROVECTUS BIOPHARMACEUTICALS, INC. | 17 Jun 2021 | 3 | $0 | 4 | COO, Director | 22 Jun 2021, 17:23 |